Evidence map›Paper›PMID 36148893›Full record

ArticleThe Milbank quarterly2022

Hospital-at-Home: Multistakeholder Considerations for Program Dissemination and Scale.

Kushal T Kadakia, Celynne A Balatbat, Albert L Siu, I Glenn Cohen, Consuelo H Wilkins, Victor J Dzau, Anaeze C Offodile 2nd

Abstract read
In one paragraph

Article in The Milbank quarterly, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kushal T KadakiaHarvard Medical School.
Celynne A BalatbatNational Academy of Medicine.
Albert L SiuIcahn School of Medicine at Mount Sinai.
I Glenn CohenHarvard Law School.
Consuelo H WilkinsVanderbilt University Medical Center.
Victor J DzauNational Academy of Medicine.
Anaeze C Offodile 2ndUniversity of Texas MD Anderson Cancer Center.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Policy Points Hospital-at-Home (HaH) is a home-based alternative for acute care that has expanded significantly under COVID-19 regulatory flexibilities. The post-pandemic policy agenda for HaH will require consideration of multistakeholder perspectives, including patient, caregiver, provider, clinical operations, technology, equity, legal, quality, and payer. Key policy challenges include reaching a consensus on program standards, clarifying caregivers' issues, creating sustainable reimbursement mechanisms, and mitigating potential equity concerns. Key policy prescriptions include creating a national surveillance system for quality and safety, clarifying legal standards for care in the home, and deploying payment reforms through value-based models.

Indexed as

COVID-19CaregiversHospitalsHumansReimbursement Mechanisms

Identifiers

PMID36148893
PMCPMC9576240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.